Supplementary protection
LT - Priešvėžinis vaistas, turintis alfa, alfa, alfa-trifluortimidino ir timidinfosforilazės inhibitorių
EN - ANTICANCER DRUG CONTAINING ALPHA, ALPHA, ALPHA-TRIFLUOROTHYMIDINE AND THYMIDINE PHOSPHORYLASE INHIBITOR
SPC
| (11) |
Number of the document |
C 1849470 |
| (68) |
Number of the document |
1849470
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2017 024 |
| (22) |
Date of filing the application |
2017-07-28 |
| (41) |
Date of publication of the application |
2017-08-10 |
|
Date of publication of SPC |
2019-10-25 |
| (24) |
Date of coming into effect of SPC |
2026-01-26 |
Applicant
| (71) |
Taiho Pharmaceutical Co., Ltd.,
1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444,
JP
|
Grantee
| (73) |
Taiho Pharmaceutical Co., Ltd.,
1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444,
JP
|
Attorney or representative
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/16/1096, 2016-04-25
|
Calculated date of expiry of the SPC
| (94) |
2031-01-25 |
Name of the product protected by the basic patent
| (95) |
Trifluridinas/Tipiracilas |
